Fairbanks Institute (Fairbanks) is a US based non profit organization. It is engaged in improving community and public health by assisting the progress of research breakthroughs, which leads to better ways for the prevention, diagnosis and treatment of chronic diseases. The novel research platform of the company is in clinical indications for coronary artery disease (CAD). It is based on the integration of biological samples collected from the people of Indianapolis and other Indiana communities. The company also provides academic and commercial access to biological samples and information for research. Recently, the company entered into partnership with BioServe. Fairbanks is headquartered at Indianapolis, Indiana, the US.